Aytu Biopharma (AYTU) Deferred Taxes (2014)
Aytu Biopharma (AYTU) posted quarterly Deferred Taxes of -$1.0 for Q4 2014, up 100.0% quarter-over-quarter from -$23909.0 in Q3 2014.
Aytu Biopharma (AYTU) Deferred Taxes (2014) Analysis & Trends
Aytu Biopharma (AYTU) has reported Deferred Taxes for 1 consecutive years, with -$1.0 the latest figure, recorded in Q4 2014.
- In Q4 2014, Deferred Taxes changed N/A year-over-year to -$1.0; the TTM figure through Dec 2015 stood at -$1.0 (changed N/A YoY), while the FY2015 annual figure was -$23910.0, up 97.06% from the prior year.
- Deferred Taxes rose to -$1.0 in Q4 2014 per AYTU's latest filing, from -$23909.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at -$1.0 in Q4 2014 and bottomed at -$23909.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -1.00 |
| Sep 30, 2014 | -23,909.00 |